Literature DB >> 22802614

Molecular mechanisms used by chaperones to reduce the toxicity of aberrant protein oligomers.

Benedetta Mannini1, Roberta Cascella, Mariagioia Zampagni, Maria van Waarde-Verhagen, Sarah Meehan, Cintia Roodveldt, Silvia Campioni, Matilde Boninsegna, Amanda Penco, Annalisa Relini, Harm H Kampinga, Christopher M Dobson, Mark R Wilson, Cristina Cecchi, Fabrizio Chiti.   

Abstract

Chaperones are the primary regulators of the proteostasis network and are known to facilitate protein folding, inhibit protein aggregation, and promote disaggregation and clearance of misfolded aggregates inside cells. We have tested the effects of five chaperones on the toxicity of misfolded oligomers preformed from three different proteins added extracellularly to cultured cells. All the chaperones were found to decrease oligomer toxicity significantly, even at very low chaperone/protein molar ratios, provided that they were added extracellularly rather than being overexpressed in the cytosol. Infrared spectroscopy and site-directed labeling experiments using pyrene ruled out structural reorganizations within the discrete oligomers. Rather, confocal microscopy, SDS-PAGE, and intrinsic fluorescence measurements indicated tight binding between oligomers and chaperones. Moreover, atomic force microscopy imaging indicated that larger assemblies of oligomers are formed in the presence of the chaperones. This suggests that the chaperones bind to the oligomers and promote their assembly into larger species, with consequent shielding of the reactive surfaces and a decrease in their diffusional mobility. Overall, the data indicate a generic ability of chaperones to neutralize extracellular misfolded oligomers efficiently and reveal that further assembly of protein oligomers into larger species can be an effective strategy to neutralize such extracellular species.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22802614      PMCID: PMC3411936          DOI: 10.1073/pnas.1117799109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

Review 1.  Novel insights into the mechanism of chaperone-assisted protein disaggregation.

Authors:  Jimena Weibezahn; Christian Schlieker; Peter Tessarz; Axel Mogk; Bernd Bukau
Journal:  Biol Chem       Date:  2005-08       Impact factor: 3.915

2.  A causative link between the structure of aberrant protein oligomers and their toxicity.

Authors:  Silvia Campioni; Benedetta Mannini; Mariagioia Zampagni; Anna Pensalfini; Claudia Parrini; Elisa Evangelisti; Annalisa Relini; Massimo Stefani; Christopher M Dobson; Cristina Cecchi; Fabrizio Chiti
Journal:  Nat Chem Biol       Date:  2010-01-10       Impact factor: 15.040

3.  Chaperone proteostasis in Parkinson's disease: stabilization of the Hsp70/alpha-synuclein complex by Hip.

Authors:  Cintia Roodveldt; Carlos W Bertoncini; August Andersson; Annemieke T van der Goot; Shang-Te Hsu; Rafael Fernández-Montesinos; Jannie de Jong; Tjakko J van Ham; Ellen A Nollen; David Pozo; John Christodoulou; Christopher M Dobson
Journal:  EMBO J       Date:  2009-10-29       Impact factor: 11.598

4.  The acute phase protein haptoglobin is a mammalian extracellular chaperone with an action similar to clusterin.

Authors:  Justin J Yerbury; Mark S Rybchyn; Simon B Easterbrook-Smith; Cindy Henriques; Mark R Wilson
Journal:  Biochemistry       Date:  2005-08-16       Impact factor: 3.162

5.  Alpha2-macroglobulin attenuates beta-amyloid peptide 1-40 fibril formation and associated neurotoxicity of cultured fetal rat cortical neurons.

Authors:  Y Du; K R Bales; R C Dodel; X Liu; M A Glinn; J W Horn; S P Little; S M Paul
Journal:  J Neurochem       Date:  1998-03       Impact factor: 5.372

6.  Role of alpha2-macroglobulin in regulating amyloid beta-protein neurotoxicity: protective or detrimental factor?

Authors:  C Fabrizi; R Businaro; G M Lauro; L Fumagalli
Journal:  J Neurochem       Date:  2001-07       Impact factor: 5.372

7.  The interaction of alphaB-crystallin with mature alpha-synuclein amyloid fibrils inhibits their elongation.

Authors:  Christopher A Waudby; Tuomas P J Knowles; Glyn L Devlin; Jeremy N Skepper; Heath Ecroyd; John A Carver; Mark E Welland; John Christodoulou; Christopher M Dobson; Sarah Meehan
Journal:  Biophys J       Date:  2010-03-03       Impact factor: 4.033

8.  Clusterin (apoJ) alters the aggregation of amyloid beta-peptide (A beta 1-42) and forms slowly sedimenting A beta complexes that cause oxidative stress.

Authors:  T Oda; P Wals; H H Osterburg; S A Johnson; G M Pasinetti; T E Morgan; I Rozovsky; W B Stine; S W Snyder; T F Holzman
Journal:  Exp Neurol       Date:  1995-11       Impact factor: 5.330

9.  A comparison of the biochemical modifications caused by toxic and non-toxic protein oligomers in cells.

Authors:  Mariagioia Zampagni; Roberta Cascella; Fiorella Casamenti; Cristina Grossi; Elisa Evangelisti; Daniel Wright; Matteo Becatti; Gianfranco Liguri; Benedetta Mannini; Silvia Campioni; Fabrizio Chiti; Cristina Cecchi
Journal:  J Cell Mol Med       Date:  2011-10       Impact factor: 5.310

10.  The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures.

Authors:  Justin J Yerbury; Stephen Poon; Sarah Meehan; Brianna Thompson; Janet R Kumita; Christopher M Dobson; Mark R Wilson
Journal:  FASEB J       Date:  2007-04-05       Impact factor: 5.191

View more
  61 in total

1.  Aggregation modulators interfere with membrane interactions of β2-microglobulin fibrils.

Authors:  Tania Sheynis; Anat Friediger; Wei-Feng Xue; Andrew L Hellewell; Kevin W Tipping; Eric W Hewitt; Sheena E Radford; Raz Jelinek
Journal:  Biophys J       Date:  2013-08-06       Impact factor: 4.033

Review 2.  Extracellular small heat shock proteins: exosomal biogenesis and function.

Authors:  V Sudhakar Reddy; Satish K Madala; Jamma Trinath; G Bhanuprakash Reddy
Journal:  Cell Stress Chaperones       Date:  2017-10-30       Impact factor: 3.667

3.  Amorphous protein aggregates stimulate plasminogen activation, leading to release of cytotoxic fragments that are clients for extracellular chaperones.

Authors:  Patrick Constantinescu; Rebecca A Brown; Amy R Wyatt; Marie Ranson; Mark R Wilson
Journal:  J Biol Chem       Date:  2017-07-14       Impact factor: 5.157

4.  Chaperonin GroEL accelerates protofibril formation and decorates fibrils of the Het-s prion protein.

Authors:  Marielle A Wälti; Thomas Schmidt; Dylan T Murray; Huaibin Wang; Jenny E Hinshaw; G Marius Clore
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-07       Impact factor: 11.205

5.  Rational design of potent domain antibody inhibitors of amyloid fibril assembly.

Authors:  Ali Reza A Ladiwala; Moumita Bhattacharya; Joseph M Perchiacca; Ping Cao; Daniel P Raleigh; Andisheh Abedini; Ann Marie Schmidt; Jobin Varkey; Ralf Langen; Peter M Tessier
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-15       Impact factor: 11.205

6.  The peculiar role of the A2V mutation in amyloid-β (Aβ) 1-42 molecular assembly.

Authors:  Massimo Messa; Laura Colombo; Elena del Favero; Laura Cantù; Tatiana Stoilova; Alfredo Cagnotto; Alessandro Rossi; Michela Morbin; Giuseppe Di Fede; Fabrizio Tagliavini; Mario Salmona
Journal:  J Biol Chem       Date:  2014-07-18       Impact factor: 5.157

Review 7.  Innovative strategies to treat protein misfolding in inborn errors of metabolism: pharmacological chaperones and proteostasis regulators.

Authors:  Ania C Muntau; João Leandro; Michael Staudigl; Felix Mayer; Søren W Gersting
Journal:  J Inherit Metab Dis       Date:  2014-04-01       Impact factor: 4.982

8.  The noncanonical small heat shock protein HSP-17 from Caenorhabditis elegans is a selective protein aggregase.

Authors:  Manuel Iburg; Dmytro Puchkov; Irving U Rosas-Brugada; Linda Bergemann; Ulrike Rieprecht; Janine Kirstein
Journal:  J Biol Chem       Date:  2020-01-30       Impact factor: 5.157

9.  Antiapoptotic properties of α-crystallin-derived peptide chaperones and characterization of their uptake transporters in human RPE cells.

Authors:  Parameswaran G Sreekumar; Paresh Chothe; Krishna K Sharma; Rinku Baid; Uday Kompella; Christine Spee; Nandini Kannan; Christina Manh; Stephen J Ryan; Vadivel Ganapathy; Ram Kannan; David R Hinton
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-04-17       Impact factor: 4.799

10.  Repurposing Hsp104 to Antagonize Seminal Amyloid and Counter HIV Infection.

Authors:  Laura M Castellano; Stephen M Bart; Veronica M Holmes; Drew Weissman; James Shorter
Journal:  Chem Biol       Date:  2015-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.